American News World - News And Technology

As shares of Boston Scientific Corp. traded at their lowest value in more than 13 years, a UBS analyst began coverage with a "Buy" rating, due to the price and the company’s cost cuts.

This entry was posted on Thursday, November 20th, 2008 at 2:24 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.